Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carl Gommoll
Erratum To: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results From an Open-Label, 48-Week Extension Study
Clinical Drug Investigation
Medicine
Pharmacology
Related publications
Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Efficacy, Safety and Tolerability of Escitalopram in Doses Up to 50 Mg in Major Depressive Disorder (MDD): An Open-Label, Pilot Study
BMC Psychiatry
Psychiatry
Mental Health
Efficacy and Tolerability of Escitalopram in Treatment of Major Depressive Disorder With Anxiety Symptoms: A 24-Week, Open-Label, Prospective Study in Chinese Population
Neuropsychiatric Disease and Treatment
Aripiprazole in Children and Adolescents With Tourette's Disorder: An Open-Label Safety and Tolerability Study
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Safety, Tolerability, and Efficacy of Vortioxetine (Lu AA21004) in Major Depressive Disorder
International Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
Safety and Tolerability of Desvenlafaxine in Children and Adolescents With Major Depressive Disorder
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder
Journal of Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
Symtomatic Factors in Patients With Major Depressive Disorder (MDD): Results From an Observational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental